Psychological distress and coping in nasopharyngeal cancer: an explorative study in Western Europe by Ghiggia, Ada et al.
This full text was downloaded from iris - AperTO: https://iris.unito.it/
iris - AperTO
University of Turin’s Institutional Research Information System and Open Access Institutional Repository
This is the author's final version of the contribution published as:
Ghiggia, Ada; Castelli, Lorys; Riva, Giuseppe; Tesio, Valentina; Provenzano,
Erica; Ravera, Mattia; Garzaro, Massimiliano; Pecorari, Giancarlo; Franco,
Pierfrancesco; Potenza, Ilenia; Rampino, Monica; Torta, Riccardo.
Psychological distress and coping in nasopharyngeal cancer: an explorative
study in Western Europe. PSYCHOLOGY, HEALTH & MEDICINE. Epub
ahead of print (-) pp: 1-13.
DOI: 10.1080/13548506.2016.1220600
The publisher's version is available at:
https://www.tandfonline.com/doi/full/10.1080/13548506.2016.1220600
When citing, please refer to the published version.
Link to this full text:
http://hdl.handle.net/2318/1605379
 1 
Psychological distress and coping in Nasopharyngeal Cancer: 
an explorative study in Western Europe 
 
Ada Ghiggiaa, Lorys Castellia,*, Giuseppe Rivab, Valentina Tesioa, Erica Provenzanob, Mattia 
Raverab, Massimiliano Garzarob, Giancarlo Pecorarib, Pierfrancesco Francoc, Ilenia Potenzac, 
Monica Rampinoc, Riccardo Tortad. 
 
a Department of Psychology, University of Turin, Via Verdi 8, 10124, Turin, Italy. Tel. +39 
011 6703051 
b First Ear Nose and Throat Division, Department of Surgical Sciences, University of Turin, 
Corso Bramante 88/90, 10126, Turin, Italy. Tel. +39 011.633.6648 / 4604 
c Radiation Oncology Unit, Department of Oncology, University of Turin, Corso Bramante 
88/90, 10126, Turin, Italy. Tel: +39 011 6705352  
d Clinical and Oncological Psychology, Department of Neuroscience, “Città della Salute e della 
Scienza” Hospital of Turin, Corso Bramante 88/90, 10126, Turin, Italy. Tel: +39 011 6334200. 
 2 
 
*Corresponding author: Lorys Castelli; email: lorys.castelli@unito.it.  
Telephone: +39 011 0913050; Fax: + 39 011 8146231 
Postal address: Lorys Castelli, PhD, c/o Department of 
Psychology, University of Turin, Via Po 14, 10123, Turin, Italy. 
 
Ada Ghiggia   ada.ghiggia@unito.it 
Lorys Castelli  lorys.castelli@unito.it 
Giuseppe Riva  giuseppe.riva84@gmail.com 
Valentina Tesio  valentina.tesio@unito.it 
Erica Provenzano  provenzanoerica@hotmail.it 
Mattia Ravera  mattia.ravera@hotmail.it 
Massimiliano Garzaro garz@libero.it 
Giancarlo Pecorari  pecorarig@yahoo.it 
Pierfrancesco Franco pierfrancesco.franco@unito.it 
Ilenia Potenza  ilenia.potenza@gmail.com 
Monica Rampino  monicaramp100@gmail.com 
Riccardo Torta  riccardo.torta@unito.it 
 
Conflicts of interest 
The authors declare no conflicts of interest. 
Financial support 
This study was performed without any financial or other contractual agreements that may 
cause conflicts of interest. 
 3 
Abstract 
Nasopharyngeal carcinoma (NPC) is the head and neck cancer with the greatest impact on 
patients’ quality of life. The aim of this explorative study is to investigate the psychological 
distress, coping strategies and quality of life of NPC patients in the post-treatment 
observation period. 
Twenty-one patients disease-free for at least two years were assessed with a medical and a 
psycho-oncological evaluation. Clinically relevant depressive symptoms (CRD) were present 
in 23.8% of patients and 33.3% reported clinically relevant anxiety symptoms (CRA). 
Patients with CRD and CRA showed a significantly higher score in the use of 
hopelessness/helplessness and anxious preoccupation coping strategies and a worse quality of 
life. Even in the post-treatment period, about a quarter of patients showed CRD and CRA. 
Results showed that patients with high anxiety or depressive symptoms seem to use 
dysfunctional coping strategies, such as hopelessness and anxious preoccupation, more than 
patients with lower levels of anxiety and depression. The use of these styles of coping thus 
seems to be associated to a higher presence of CRA or CRD symptomatology and to a worse 
quality of life. 
 
Keywords: psychological distress, nasopharyngeal cancer, coping, quality of life, 
psychoncology. 
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Introduction 
The impact of cancer diagnosis, and eventual treatments, may cause psychological issues and 
impairment of patients’ quality of life that may continue in time in long-term cancer 
survivors (Sherman, Simonton, Adams, Vural & Hanna, 2000). 
Of head and neck tumors, nasopharyngeal cancer (NPC) has the greatest impact on patients’ 
quality of life (He & Liu, 2005; Fang et al., 2002). 
NPC is relatively uncommon in Western Europe compared to countries in the Far East. 
Official surveys of the International Agency for Research on Cancer (IARC) have estimated 
that the incidence of NPC in China in 2002 was 22.2 new cases in men and 9.8 in women per 
100,000 inhabitants annually; in Europe the incidence was 0.3-0.4 new cases in men and 0.1-
0.2 in women per 100000 inhabitants annually (Parkin, Bray, Ferlay & Pisani, 2002). 
At present, most studies on NPC have been conducted in countries in the Far East, whereas 
only few data may be found in Western Europe with regard to psychosocial distress and 
coping style, i.e. the adaptation processes undertaken by individuals in stressful life events 
(Lee et al., 2007; Lai et al., 2003; Folkman, Lazarus, Gruen & DeLongis, 1986). 
The prognosis for patients with NPC depends strongly on the stage of the disease at the time 
of diagnosis (Skinner & Van Hasselt, 1990; Epstein & Jones, 1993). Patients with advanced 
stages of head and neck cancer have physical limitations, associated with high psychological 
distress and a negative impact on daily life functioning (Fang et al., 2002). 
The most frequent treatment for NPC is a combination of radiotherapy (RT) and 
chemotherapy. This has a non-negligible burden of side effects that may cause a series of 
adverse reactions in patients and thus impact negatively on the patient’s global health (Oates 
et al., 2007; Marucci et al., 2012). 
These symptoms may occur not only during treatment or the following few months but even 
later, and vary according to an individual’s characteristics (Lue, Huang & Chen, 2008). 
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Although coping strategies can have an important impact on health status, to date only a few 
studies have investigated this issue in head and neck cancer patients, particularly in the 
context of NPC (Sherman et al., 2000; He & Liu, 2005; Elani & Allison, 2011; Airoldi et al., 
2011). These studies focused on coping strategies and anxious/depressive symptomatology in 
different phases of treatment, but only a few explored how psychological distress may impact 
on quality of life and coping strategies (Lue et al., 2008; Elani & Allison, 2011). 
Our preliminary exploratory study focused on a group of NPC patients during their post-
treatment observation period, in order to addressed two goals: 
1. To investigate the quality of life, psychological distress and coping strategies of patients 
with NPC. 
1. To compare any differences in the quality of life and coping strategies between patients 
with high and patients with low levels of psychological distress. 
Materials and methods 
Patients and procedure 
In this explorative study, all patients with a previous diagnosis of NPC and no evidence of the 
disease for at least two years were enrolled at the First Ear Nose and Throat (1st ENT) 
Division, Department of Surgical Sciences, at the University of Turin, during their post-
treatment observation period. All patients had undergone chemo-radiation therapy for NPC, 
according to institutional protocols. 
Exclusion criteria were: (1) second primary or disease relapses during follow-up, (2) 
neurological diseases, (3) severe psychiatric pathologies. 
Of the 52 consecutively patients in the post-treatment period who attended the clinic and 
satisfied the inclusion criteria, 4 did not present themselves, 15 died, 9 were excluded due to 
complications, relapse or neurological disorder, and 3 did not provide consent. The remaining 
21 gave their written informed consent to participate in the study. Institutional Review Board 
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approval was obtained. During a routine follow-up visit, all the patients were assessed for 
psychological status after the standard clinical evaluation. The main demographic, clinical 
features and chemo-radiotherapy characteristics are listed in Table 1. No statistically 
significant differences were detected in the socio-demographic and clinical characteristics 
between included and excluded patients. 
Medical evaluation 
The Karnofsky Performance Status (KPS) scale was administered to measure the level of the 
patients’ functional impairments and medical care requirements (Buccheri, Ferrigno & 
Tamburini, 1996). 
All subjects underwent evaluation of signs and symptoms (rhinorrea, nasal obstruction, 
xerostomy, reduced or altered taste and smell function), objective oropharyngeal evaluation 
and endoscopic fiber optic nasal examination. 
In order to evaluate late/long-term effects of radiation therapy on NPC patients, we used the 
Radiation Therapy Oncology Group (RTOG)–European Organization for Research and 
Treatment of Cancer (EORTC) late radiation morbidity scoring system, which is widely 
employed both for clinical and research purposes (Cooper, Fu, Marks & Silverman, 1995). 
Psychological assessment 
Psychological distress 
The level of anxiety and depression was assessed by a self-report questionnaire specifically 
developed for subjects with a medical illness, the Hospital Anxiety and Depression Scale 
(HADS) (Zigmond & Snaith, 1983; Kobayashi, Sugimoto, Matsuda, Matsushima & 
Kishimoto, 2008; Katz, Kopek, Waldron & Devins, 2004). It is divided into two subscales, 
each with 7 items coded in a Likert scale from 0 to 3. For both HADS subscales, we adopted 
a validated and commonly used cut-off point of 8 to dichotomize the levels of psychological 
symptoms (Wang et al., 2011; Castelli, Binaschi, Caldera, Mussa & Torta, 2011). 
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The Distress Thermometer (DT) is a visual analog scale for assessing the patient’s level of 
distress from 0 (“no distress”) to 10 (“extreme distress”), with a score of 4 or more indicating 
significant levels of distress (Grassi et al., 2013; Castelli et al., 2015). 
Coping Strategies 
The short version of the Mental Adjustment to Cancer Scale (Mini-MAC) was administered 
to measure the following coping strategies: helplessness/hopelessness, anxious 
preoccupation, fighting spirit, cognitive avoidance, and fatalism (Grassi et al., 2005; Wang, 
Tu, Liu, Yeh & Hsu, 2013). It is a self-report scale of 29 items, each question rated on a 4-
point Likert scale, from 1 (“definitely does not apply to me”), to 4 (“definitely applies to 
me”). 
Quality of life 
The Italian version of the European Organisation for Research and Treatment of Cancer 
Quality-of-Life-Questionnaire-C30 (EORTC QLQ-C30) and the European Organisation for 
Research and Treatment of Cancer Quality-of-Life Questionnaire-Head and Neck 35 
(EORTC QLQ-H&N35) were administered. The EORTC QLQ-C30 assesses the quality of 
life (QoL) in patients with cancer; it includes a global score, five functional scales, three 
symptomatic scales and six single items for symptoms. Whereas higher scores for 
symptomatic areas indicate a lower QoL and severe symptoms, higher scores for the global 
QoL suggest a better level of functioning. The EORTC QLQ-H&N35 is a specific 
questionnaire for subjects with head and neck cancer. It assesses the gravity of the symptoms, 
and is divided into 6 multiple-item scales and 11 single-items; a high score for the symptom 
scales or items represents a high level of symptomatology (Al-Mamgani et al., 2013). 
Statistical analysis 
All statistical analyses were performed using the Statistical Package for Social Science – for 
Windows, Version 21.0 (SPSS Inc., Chicago, IL, USA). 
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Descriptive statistics were used to describe socio-demographic, clinical and psychological 
data. Given the small sample size, patients with and without clinically relevant depression 
and anxiety (CRD vs. no-CRD; CRA vs. no-CRA) were compared by means of non-
parametric statistics (Mann-Whitney U tests for independent samples). 
For all analyses, p values < .05 were considered statistically significant. 
Results 
Medical evaluation 
Chemo-radiotherapy schemes are given in Table 1. Cisplatin-based concurrent chemotherapy 
(CT) was administrated weekly or every three weeks; neoadjuvant CT schemes included 
cisplatin/fluorouracil or docetaxel/cisplatin/fluorouracil; finally adjuvant CT was based on 
cisplatin and fluorouracil. Radiotherapy was performed using two-dimensional (4 patients), 
conformal three-dimensional (5 patients) or intensity-modulated techniques (12 patients). 
Only 2 patients underwent selective or type III modified radical neck dissection for persistent 
nodal disease. 
In the medical evaluation, the main symptoms were nasal obstruction (48%), hypogeusia 
(48%) and xerostomia (81%). In addition, in the fiber optic endoscopic evaluation, 
nasopharyngeal hyperhemia and/or secretions were observed in 4% of patients. 
The RTOG/EORTC evaluation of the mucous membrane demonstrated slight-to-moderate 
toxicity (grade 1-2) in 66% of the sample (Table 2). Salivary gland functioning evaluation 
showed a moderate-to-severe impairment (grade 2–3) reported by 67% of the patients. 
Psychological distress 
The mean scores of the psychological distress variables (HADS and DT) are listed in Table 
1. Overall, the results showed a moderate percentage of patients with clinically relevant 
depression (CRD) and anxiety (CRA) or distress symptoms. Five patients out of 21 (23.8%) 
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reported CRD while 7 out of 21 (33.3%) reported CRA. As far as the DT was concerned, 9 
patients out of 21 (42.9%) showed a clinically relevant level of distress. 
Coping strategies 
MINI-MAC results evidenced that fighting spirit, cognitive avoidance and fatalism were used 
more than hopelessness/helplessness or anxious preoccupation (Table 1). 
Quality of life 
Table 3 summarizes the results of the EORTC QLQ-C30 and QLQ-H&N35 on the quality of 
life. The total sample reported a relatively good level of perceived global health status (73.7 ± 
19.0) and high levels of overall QoL (physical, role, emotional, cognitive and social 
functioning). 
CRD vs. no-CRD and CRA vs. no-CRA 
Comparing patients with and without clinically relevant symptoms of depression (CRD vs. 
no-CRD) (Table 4), we found a statistically significant difference in the following coping 
strategies subscales: hopelessness/helplessness (p = .010) and anxious preoccupation (p = 
.025), while no differences were found in the other coping subscales. 
Comparing patients with and without clinically relevant anxiety symptoms (CRA vs. no- 
CRA) (Table 4), we found a statistically significant difference in the following coping style 
strategies: hopelessness/helplessness (p = .010), anxious preoccupation (p = .013) and 
fatalism (p = .030). 
As far as quality of life was concerned (EORTC QLQ C-30) (Table 5), patients with CRD 
reported statistically lower scores in physical functioning (p = .011), role functioning (p = 
.008) and emotional functioning (p = .022) and a statistically significant higher score in the 
symptom scale of appetite loss (p = .008). 
Patients with CRA (Table 5) showed significantly poorer functioning in role (p < .001), 
emotional (p = .004), cognitive (p = .016) and social (p = .041) subscales than patients 
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without CRA. On the symptoms scales, fatigue was significantly more severe (p < .047) in 
patients with CRA compared to those without CRA. 
On the EORTC QLQ-H&N35 (Table 5), patients with CRD reported significantly higher 
scores on the symptoms scale with regard to senses problems (p = .005), trouble with social 
eating (p = .001), less sexuality (p = .003) and opening the mouth (p = .007). Patients with 
CRA reported higher scores on the symptoms scales, i.e., trouble with social eating (p = .003) 
and social contact (p = .003), less sexuality (p = .004), teeth (p = .009) and a tendency to feel 
pain (p = .052) than patients without CRA. 
Discussion 
This explorative study aimed to investigate the psychological profile of patients with NPC 
treated with combined radiotherapy and chemotherapy during their post-treatment 
observation period. While many studies on this pathology have been conducted in countries 
in the Far East, to our knowledge, studies on coping strategies and psychological distress in 
NPC patients have not yet been performed in Western nations. Therefore, this is the first 
study to simultaneously investigate psychological distress, coping strategies and quality of 
life in a sample of NPC western patients. 
Depression and anxiety are both frequent co-morbid psychiatric conditions found among 
cancer patients and may happen at any moment of the disease’s history, from diagnosis to 
subsequent phases of treatment (Hong & Tian, 2013; Deng, Zhong & Jiang, 2014). 
Psychological distress is also linked to decreased social functioning, cognitive and physical 
impairment and reduced adherence to treatments, all factors that can result in an increased 
likelihood of cancer recurrence (Zabora, BrintzenhofeSzoc, Curbow, Hooker & Piantadosi, 
2001). 
Although only a few studies have been carried out on the emotional status of NPC patients, 
depression and anxiety symptoms have been frequently detected in NPC patients. In a study 
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on 43 NPC patients, Lue et al (2008) found a prevalence of anxiety and depressive symptoms 
of 51.2% and 44.2%, respectively, detected by the Beck Anxiety Inventory and the Beck 
Depression Inventory–II. Ma (1995) found high levels of psychological distress at the time of 
diagnosis, with a decrease of these symptoms during post-treatment stages. Deng et al. (2014) 
also found that distress, measured by the DT, varied significantly between the time of 
diagnosis and chemoradiotherapy phases in NPC patients. The DT was found to be the lowest 
at the time of diagnosis, whilst when the treatment started, the number of patients with 
distress gradually increased (Deng et al., 2014). 
In our study, almost half of the patients (42.9%) showed a score above the cut-off for DT, 
despite the fact that the assessment was made in the post-treatment period. In addition, using 
the HADS, one of the most widely used tools to evaluate the level of psychological distress in 
cancer populations (Zigmond & Snaith, 1983; Castelli et al., 2011), our study showed that 
about one quarter of patients (23.8%) reported clinically relevant depressive symptoms, while 
about one third (33.3%) experienced clinically relevant anxiety. 
Our data also highlighted that the presence of psychological distress was associated to a 
worse quality of life and with a higher use of dysfunctional coping strategies to cancer, such 
as hopelessness and anxious preoccupation. Sherman et al. (2000) suggested that patients 
with head and neck cancer use different coping strategies at different stages of the disease 
and treatments. They noted that the post-treatment period was a stressful phase, both for the 
patient and his/her family (Sherman & Simonton, 1999; Sherman et al., 2000). Between the 
few NPC studies conducted in countries in the Far East, He & Liu (2005) reported that the 
optimistic style was the most detected; Lai et al. (2003) investigated distress symptoms, hope 
and catastrophizing in 115 NPC patients during the radiation therapy and found a low overall 
score for catastrophizing that varied with a large standard deviation among patients, due to 
individual differences. 
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Previous studies conducted on different types of cancer found that adaptive strategies of 
coping seem to contribute to a person’s best response to the disease (Petticrew, Bell & 
Hunter, 2002; Hassanein, Musgrove & Bradbury, 2005). In a study on head and neck cancer, 
Kugaya, Akechi, Okamura, Mikami & Uchitomi (1999) used the Mental Adjustment to 
Cancer (MAC) scale to evaluate the coping strategies adopted by patients, and showed that a 
depressed mood was associated with the helplessness/hopelessness strategy (Grassi, Rosti, 
Lasalvia & Marangolo, 1993). Elani & Allison (2011), in a longitudinal study on head and 
neck cancer, compared patients according to their combined levels of anxiety and depression, 
to evaluate whether patients with low levels of psychological distress adopted different styles 
of coping. They found that higher levels of anxiety and depression were associated with 
“blamed self”, “wishful thinking” and “avoidance” coping strategies. 
In line with the literature, we found that patients with high anxiety or depressive symptoms 
seem to use dysfunctional coping strategies, such as hopelessness and anxious preoccupation, 
more than patients with lower levels of anxiety and depression. The use of these styles of 
coping thus seems to be associated to a higher presence of CRA or CRD symptomatology 
and to a worse quality of life. 
NPC patients usually undergo a multimodal treatment that impacts heavily on their quality of 
life and physical functionality. The standard care for advanced NPC disease is concomitant 
chemoradiotherapy, which usually results in a series of side effects: swallowing dysfunction, 
dry mouth, sense and speech problems, issues with social eating and social contact (Airoldi et 
al., 2011; Chaturved, Shenoy, Prasad, Senthilnathan & Premlatha, 1996). All these 
complications may compromise social functioning. In the late toxicity evaluation, our sample 
reported slight-to-moderate impairment of the mucous membrane and salivary gland 
function. These data were observed in previous studies on patients treated for head and neck 
cancer (Oates et al., 2007; Cooper et al., 1995). 
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In the present study, we assess quality of life using the EORTC QLQ-H&N35, a site-specific 
module for head and neck cancer patients, as a supplement to the EORTC QLQ-C30, a 
questionnaire developed to measure the QoL of mixed cancer patients. Several studies have 
evaluated the different effects of radiation therapy on the quality of life of patients with NPC 
in the different stages of treatment, from pre- to post- radiotherapy or chemotherapy (Lee et 
al., 2007; Oates et al., 2007). 
Our results highlighted a relatively good level of perceived global health status and high 
levels of overall functional scales. Similarly, a study of Lue et al. (2008), in a cohort of 43 
NPC patients complicated by post-radiotherapy endocrinopathy, found that emotional and 
cognitive functional scales were significantly affected. 
Regarding the site-specific module of the EORTC QLQ-H&N35, we found that patients with 
depressive and anxiety symptoms reported more serious symptoms. The overall scores 
showed higher scores in problems regarding teeth, dry mouth and sticky saliva, as already 
found by previous studies (Lue et al., 2008; Cengiz, Ozyar & Esassolak, 2005). 
The main limitation of this explorative study is the small size of the sample. Although this 
limitation reflects the low prevalence of NPC in the Western population, the limited number 
of patients affects the statistical power of the study, which results underpowered. Therefore 
our preliminary results have to be interpreted with caution and should not be generalized to 
the larger population. Further longitudinal studies with a higher number of patients are 
necessary to better evaluate the relationship between psychological distress, coping and 
quality of life at different stages of the disease/treatments. 
In conclusion, our exploratory study is the first in a Western country to simultaneously 
evaluate the psychological distress, coping strategies and quality of life in NPC patients. We 
found that even during the post-treatment observation period a moderate percentage of 
patients showed clinically relevant anxiety and depressive symptoms. Furthermore, the 
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psychological distress seems to be associated with a higher use of dysfunctional coping 
strategies, such as hopelessness/helplessness and anxious preoccupation and with a lower 
quality of life, especially in the functional scales. In addition, specific symptoms of NPC 
patients - such as trouble with social eating and opening the mouth - appeared to be 
associated with the presence of psychological distress. These findings suggest the need for 
further longitudinal studies exploring the association between psychological distress and 
coping strategies over time, in order to organize the psychological interventions and to 
facilitate the use of more adaptive coping strategies for dealing with the disease, thus 
reducing further negative impacts on the quality of life of the patients. 
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Table 1. Demographic, clinical and psychological variables 
 N = 21 
Sex (N (%))  
Female 3 (14.3) 
Male 18 (85.7) 
Age (yeras)  
Mean ± SD 54.1 ± 12.0 
Time after last radiotherapy (months)  
Mean ± SD 67 ± 29.6 
Range 26-124 
Educational Level (N (%))  
Basic education (ISCED 0-2) 12 (57) 
Secondary education (ISCED 3/4) 9 (43) 
Tertiary education (ISCED 5/6) 0 (0) 
Stage of Cancer  (N (%))  
I 1 (4.8) 
II 4 (19) 
III 9 (42.9) 
IV 7 (33.3) 
Karnofsky Performance Status Index  
Mean ± SD 95.7 ± 5.1 
Treatment schemes (N (%))  
Concurrent chemoradiotherapy 3 (14) 
Concurrent chemoradiotherapy + adjuvant chemotherapy 4 (19) 
Neoadjuvant chemotherapy+concurrent chemoradiotherapy 14 (67) 
Radiation doses (Gy)  
Total Fractionated Dose to T 69.4 ± 1.1 
Dose to low-risk nodes 51.0 ± 11.1 
Dose to high-risk nodes 59.0 ± 1.9 
Dose to left parotid gland 39.9 ± 14.8 
Dose to right parotid gland 39.3 ± 16.8 
Psychological distress (Mean ± SD)  
HADS-Depression 5.4 (4.0) 
HADS-Anxiety 5.9 (3.8) 
Distress Thermometer (DT) 3.1 (2.9) 
Mini-MAC (Mean ± SD)  
Hopelessness/Helplessness 1.7 (0.6) 
Anxious Preoccupation 2.4 (0.7) 
Fighting Spirit 3.1 (0.4) 
Cognitive Avoidance 2.7 (0.7) 
Fatalism 3.0 (0.5) 
Abbreviations: HADS: Hospital Anxiety and Depression Scale, cut-off score = 8. 
DT: Distress Thermometer, cut-off score = 4. 
Mini-MAC: Mini Mental Adjustment to Cancer Scale, score range 1-4, from 1 
(definitely does not apply to me) to 4 (definitely applies to me). 
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Table 2. RTOG/EORTC Late radiation morbidity scoring system, frequencies and percentages in the 21 
patients. 
Grade and mean No. of patients (%) 
Skin  
0 None 2 (10) 
1 Slight atrophy, pigmentation change, some hair loss 15 (71) 
2 Patchy atrophy, moderate teleangiectasia, total hair loss 4 (19) 
3 Marked atrophy, gross teleangiectasia 0 (0) 
4 Ulceration  0 (0) 
5 Death directly related to late effects of radiation 0 (0) 
Subcutaneous tissue  
0 None 4 (19) 
1 Slight fibrosis and loss of subcutaneous fat 13 (62) 
2 Moderate fibrosis but asymptomatic,  
slight field contracture <10% linear reduction 
3 (14) 
3 Severe fibrosis and loss of subcut neous,  
field contracture <10% linear measurements 
1 (5) 
4 N crosis 0 (0) 
5 Death directly related to radiation late effects 0 (0) 
Mucous membrane  
0 None 5 (24) 
1 Slight atrophy and dryness 10 (47) 
2 Moderate atrophy and teleangiectasia, little mucous  4 (19) 
3 Marked atrophy with complete dryness, severe teleangiectasia 2 (10) 
4 Ulcerations 0 (0) 
5 Death directly related to radiation late effects 0 (0) 
Salivary gland  
0 None 3 (14) 
1 Slight dryness of mouth, good response to stimulation 5 (24) 
2 Moderate dryness of mouth, poor response on stimulation 9 (43) 
3 Complete dryness of mouth, no response on stimulation 4 (19) 
4 Fibrosis 0 (0) 
5 Death directly related to radiation late effects 0 (0) 
Abbreviations: RTOG, Radiation Therapy Oncology Group;  
                        EORTC, European Organization for Research and Treatment of Cancer. 
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Table 3. Quality of life: EORTC QLQ-C30 and EORTC QLQ-H&N35 mean scores 
EORTC QLQ-C30 mean scores EORTC QLQ-H&N35 mean scores 
Scales  Mean (±SD) Symptom Scalesb Mean (±SD) 
Global Health Status – QoLa  Pain  19.4 (18.7) 
Quality of life 73.7 (19.0) Swallowing  15.5 (15.6) 
Functional Scales†   Senses problems  21.4 (23.6) 
Physical Functioning 82.5 (15.7) Speech problems  11.6 (12.9) 
Role Functioning 82.5 (25.5) Trouble with social 
eating  
17.9 (21.9) 
Emotional Functioning 81.3 (20.9) Trouble with social 
contact  
5.4 (11.1) 
Cognitive Functioning 82.5 (25.5) Less sexuality 12.7 (24.1) 
Social Functioning 85.7 (18.5) Tee h  47.6 (40.2) 
Symptom Scalesb  Opening mouth  31.7 (26.8) 
Fatigue 28.6 (24.0) Dry mouth  54.0 (34.1) 
Nausea and Vomiting 4.8 (10.7) Sticky saliva  42.9 (33.6) 
Pain 7.1 (11.3) Coughing  21.4 (27.5) 
Dyspnea 14.3 (24.9) Felt ill  12.7 (24.7) 
Insomnia  34.9 (32.4) Pain killers  28.6 (46.3) 
Appetite Loss  15.9 (27.1) Nutritional 
supplements  
9.5 (30.1) 
Constipation  17.5 (22.6) Feeding tube  9.5 (30.1) 
Diarrhea 1.6 (7.3) Weight loss 14.3 (35.9) 
Financial Difficulties  19.0 (24.9) Weight gain  14.3 (35.9) 
Abbreviations: EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality 
of Life, Questionnaire-Core 30- questions;  
EORTC QLQ-H&N35: European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire-Core 30-Head and Neck 35-questions; QoL, quality of life. 
aHigher score indicates better functioning. 
bHigher score indicates severe symptoms 
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Table 4. Comparison of Mini-MAC scores between patients with and without psychological distress. 
Depression (Mean (±SD)) 
 With 
(5 patients) 
Without 
(16 patients) 
p Value 
Hopelessness 2.3 (0.7) 1.4 (0.4) .010* 
Anxious Preoccupation 3.2 (0.8) 2.1 (0.5) .025* 
Fighting Spirit 2.9 (0.5) 3.2 (0.4) .732 
Cognitive Avoidance 2.9 (0.7) 2.7 (0.7) .984 
Fatalism 3.4 (0.5) 2.9 (0.4) .522 
Anxiety (Mean (±SD)) 
 With 
(7 patients) 
Without 
(14 patients) 
p Value 
Hopelessness 2.2 (0.7) 1.4 (0.3) .010* 
Anxious Preoccupation 2.9 (0.8) 2.1 (0.5) .013* 
Fighting Spirit 3.0 (0.4) 3.2 (0.5) .248 
Cognitive Avoidance 2.7 (0.7) 2.7 (0.7) .647 
Fatalism 3.1 (0.6) 2.93 (0.4) .030* 
Patients with and without psychological distress were compared by means of Mann Whitney U tests for 
independent samples. 
* p values <.05. 
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Table 5. Comparison of EORTC QLQ C-30 and EORTC QLQ-H&N35 scores between patients with and 
without psychological distress. 
 Depression Anxiety 
 With 
(7 patients) 
Without 
(14 patients) 
With 
(6 patients) 
Without 
(15 patients) 
EORTC QLQ C-30     
Global Health Status – QoLa 63.3 (22.5) 77.2 (17.1) 63.9 (20.2) 78.0 (17.5) 
Functional Scalesa     
Physical Functioning (PF2) 65.3 (16.6) * 87.9 (11.2) * 72.4 (19.0) 87.6 (11.3) 
Role Functioning (RF2) 66.7 (16.7) * 87.5 (26.2) * 61.9 (18.5) * 92.9 (22.4) * 
Emotional Functioning (EF) 60.0 (28.5) * 88.0 (12.9) * 63.1 (24.9) * 90.5 (10.8) * 
Cognitive Functioning (CF) 63.3 (38.0) 88.5 (18.0) 61.9 (31.5) * 92.9 (14.2) * 
Social Functioning (SF) 70.0 (27.4) 90.0 (12.1) 71.4 (23.0) * 92.9 (10.8) * 
Symptom Scalesb     
Fatigue (FA) 48.9 (30.0) 22.2 (18.6) 44.4 (26.4) * 20.6 (18.9) * 
Nausea and Vomiting (NV) 6.7 (14.9) 4.2 (9.6) 9.5 (16.3) 2.4 (6.0) 
Pain (PA) 10.0 (14.9) 6.2 (10.3) 11.9 (12.6) 4.8 (10.2) 
Dyspnea (DY) 26.7 (43.5) 10.4 (16.0) 23.8 (37.1) 9.5 (15.6) 
Insomnia (SL) 46.7 (29.8) 31.2 (33.3) 52.4 (26.2) 26.2 (32.5) 
Appetite Loss (AP) 46.7 (38.0) * 6.2 (13.4) * 33.3 (38.5) 7.1 (14.2) 
Constipation (CO) 33.3 (23.6) 12.5 (20.6) 19.0 (17.8) 16.7 (25.3) 
Diarrhea (DI) 0.0 (0.0) 2.1 (8.3) 0.0 (0.0) 2.4 (8.9) 
Financial Difficulties (FI) 33.3 (33.3) 15.0 (21.0) 28.6 (30.0) 14.3 (21.5) 
EORTC QLQ-H&N35b     
Pain  31.7 (21.6) 15.6 (16.6) 32.1 (21.7) 13.1 (13.8) 
Swallowing  25.0 (16.7) 12.5 (14.6) 15.5 (14.0) 15.5 (14.0) 
Senses problems  46.7 (21.7)* 13.5 (18.5)* 35.7 (27.9) 14.3 (18.3) 
Speech problems  17.8 (16.8) 9.7 (11.4) 19.0 (13.9) 7.9 (11.0) 
Trouble with social eating  40.0 (29.1)* 10.9 (14.2)* 36.9 (26.7)* 8.3 (10.8)* 
Trouble with social contact 14.7 (19.7) 2.5 (4.8) 14.3 (16.1)* 0.9 (2.4)* 
Less sexuality 43.3 (32.5)* 3.1 (9.1)* 33.3 (31.9)* 2.4 (8.9)* 
Teeth  66.7 (40.8) 41.7 (39.4) 80.9 (26.2)* 30.9 (35.7)* 
Opening mouth  60.0 (14.9)* 22.9 (34.4)* 47.6 (17.8) 23.8 (27.5) 
Dry mouth 73.3 (27.9) 47.9 (34.4) 71.4 (30.0) 45.2 (33.6) 
Sticky saliva  53.3 (38.0) 39.6 (32.7) 52.4 (37.8) 38.1 (31.6) 
Coughing  36.7 (24.7) 16.7 (27.2) 21.4 (28.4) 21.4 (28.1) 
Felt ill  26.7 (43.5) 8.3 (14.9) 23.8 (37.1) 7.1 (14.2) 
Pain killers  20.0 (44.7) 31.2 (47.9) 28.6 (48.8) 28.6 (46.9) 
Nutritional supplements 0.0 (0.0) 12.5 (34.2) 0.0 (0.0) 14.3 (36.3) 
Feeding tube 20.0 (44.7) 6.2 (25.0) 28.6 (48.8) 0.0 (0.0) 
Weight loss 20.0 (44.7) 12.5 (34.2) 14.3 (37.8) 14.3 (36.3) 
Weight gain  0.0 (0.0) 18.7 (40.3) 28.6 (48.8) 7.1 (26.7) 
Abbreviations: EORTC QLQ-C30, European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire-Core 30-questions; QoL, quality of life. 
EORTC QLQ-H&N35, European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire-Core 30-Head and Neck 35-questions. 
aHigher score indicates better functioning. 
bHigher score indicates severe symptoms. 
Patients with and without psychological distress were compared by means of Mann-Whitney U tests for 
independent samples. 
* p values <.05. 
  
